NCT00106262View on ClinicalTrials.gov

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

March 31, 2007

Conditions
Cervical Cancer
Interventions
DRUG

Velcade (bortezomib)

DRUG

Irinotecan

Trial Locations (1)

02905

Women & Infants' Hospital, Providence

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Women and Infants Hospital of Rhode Island

OTHER